The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, ...

Marianna Tcherpakov, PhD, director of Business Development, CMC Services, at Frontage Laboratories, spoke on the CDMO’s role ...

This article presents an overview of FDA’s recent update to the guidance document, Control of Nitrosamine Impurities in Human ...

In this episode of the Ask the Expert video series, Peter Walters, Fellow of Advanced Therapies at CRB Group, discusses how ...

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry ...

Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of recent news, including ...

Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.

Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology ...

Shawn Li, principal scientist at Merck & Co., known as MSD outside the Unites States and Canada, talked about the importance ...

A new laboratory will be built in Oss, while additional capacity and capabilities will be added to the Bioanalytical Center of Excellence in Assen.

At AAPS PharmSci 360, Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer ...